15 June 2026
: Case report
Bloodstream Infection in an Immunocompromised Host After Unusual Presentation of Photo Recall Dermatitis
Unusual or unexpected effect of treatment, Unexpected drug reaction, Rare coexistence of disease or pathology
Shanan ImmelDOI: 10.12659/AJCR.951310
Am J Case Rep 2026; 27:e951310
Table 1 Staphylococcus hominis antimicrobial susceptibility testing.
| Antibiotics | Susceptibility | Minimum inhibitory concentration (MIC) |
|---|---|---|
| Clindamycin | Susceptible | <0.5 mcg/ml |
| Daptomycin | Susceptible | <0.5 mcg/ml |
| Erythromycin | Resistant | >4 mcg/ml |
| Gentamicin | Susceptible | <4 mcg/ml |
| Levofloxacin | Susceptible | <0.25 mcg/ml |
| Linezolid | Susceptible | 2 mcg/ml |
| Moxifloxacin | Susceptible | <0.25 mcg/ml |
| Oxacillin | Susceptible | <0.25 mcg/ml |
| Penicillin | Resistant | 0.5 mcg/ml |
| Tetracycline | Susceptible | <2 mcg/ml |
| Trimethoprim/Sulfamethoxazole | Susceptible | <2 mcg/ml |
| Vancomycin | Susceptible | 1 mcg/ml |






